Skip to content

Selectis Health, Inc.: 10-Q filed 2025-08-14

What Selectis Health, Inc. reported in its quarterly report filed 2025-08-14 (fiscal Q2 2025): 36 published measures, 104 facts as tagged in accession 0001641172-25-024135.

This filing

Form
10-Q (quarterly report)
Filed
2025-08-14
Fiscal period
fiscal Q2 2025
Accession
0001641172-25-024135 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Selectis Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-3033,637,759USD
At 2024-12-3133,446,964USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-3040,034,511USD
At 2024-12-3138,857,220USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-30-6,396,752USD
At 2025-03-31-6,081,225USD
At 2024-12-31-5,410,256USD
At 2024-06-30-3,219,171USD
At 2024-03-31-4,006,015USD
At 2023-12-31-2,963,795USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-06-30559,983USD
At 2024-12-31680,332USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-308,027USD91
2025-01-01 to 2025-06-30-963,996USD181
2024-04-01 to 2024-06-30794,344USD91
2024-01-01 to 2024-06-30-240,376USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30958,032USD181
2024-01-01 to 2024-06-30-173,423USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-06-30382,755USD181
2024-01-01 to 2024-06-3026,862USD182

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-04-01 to 2025-06-3010,441,244USD91
2025-01-01 to 2025-06-3020,928,183USD181
2024-04-01 to 2024-06-309,584,802USD91
2024-01-01 to 2024-06-3019,077,208USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-635,320USD181
2024-01-01 to 2024-06-30-565,927USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-382,755USD181
2024-01-01 to 2024-06-302,457,938USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-21,178,132USD
At 2024-12-31-20,191,636USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-303,067,059shares91
2025-01-01 to 2025-06-303,067,059shares181
2024-04-01 to 2024-06-303,067,059shares91
2024-01-01 to 2024-06-303,067,059shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2025-06-303,067,059shares91
2025-01-01 to 2025-06-303,067,059shares181
2024-04-01 to 2024-06-303,067,059shares91
2024-01-01 to 2024-06-303,067,059shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.1USD/shares91
2025-01-01 to 2025-06-30-0.32USD/shares181
2024-04-01 to 2024-06-300.26USD/shares91
2024-01-01 to 2024-06-30-0.08USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.1USD/shares91
2025-01-01 to 2025-06-30-0.32USD/shares181
2024-04-01 to 2024-06-300.26USD/shares91
2024-01-01 to 2024-06-30-0.08USD/shares182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-06-3027,784,997USD
At 2024-12-3128,128,004USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-450,289USD91
2025-01-01 to 2025-06-30-872,035USD181
2024-04-01 to 2024-06-30-763,912USD91
2024-01-01 to 2024-06-30-1,460,175USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-304,003,914USD
At 2024-12-313,530,418USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-3021,234,962USD
At 2024-12-3119,627,458USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-06-301,076,908USD
At 2024-12-311,076,908USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-06-303,042,377USD
At 2024-12-312,616,929USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2025-06-3010,891,533USD91
2025-01-01 to 2025-06-3021,800,218USD181
2024-04-01 to 2024-06-3010,348,714USD91
2024-01-01 to 2024-06-3020,537,383USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-06-303,067,059shares
At 2024-12-313,067,059shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-06-301,331,923USD
At 2024-06-304,023,311USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-06-3013,852,028USD
At 2024-12-3113,852,028USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2025-06-3018,696,749USD
At 2024-12-3119,132,862USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-06-3043,369,805USD
At 2024-12-3142,987,050USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-06-3015,584,808USD
At 2024-12-3114,859,046USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-06-30401,554USD
At 2024-12-31233,157USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-315,527USD91
2025-01-01 to 2025-06-30-986,496USD181
2024-04-01 to 2024-06-30786,844USD91
2024-01-01 to 2024-06-30-255,376USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-302,236,266USD91
2025-01-01 to 2025-06-304,601,354USD181
2024-04-01 to 2024-06-302,423,021USD91
2024-01-01 to 2024-06-304,586,367USD182

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-04-01 to 2025-06-30362,742USD91
2025-01-01 to 2025-06-30725,762USD181
2024-04-01 to 2024-06-30409,530USD91
2024-01-01 to 2024-06-30833,129USD182

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-04-01 to 2025-06-30225,991USD91
2025-01-01 to 2025-06-30768,658USD181
2024-04-01 to 2024-06-30585,709USD91
2024-01-01 to 2024-06-301,216,039USD182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-04-01 to 2025-06-3041,753USD91
2025-01-01 to 2025-06-30350,197USD181
2024-04-01 to 2024-06-3031,822USD91
2024-01-01 to 2024-06-30323,695USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-04-01 to 2025-06-30142,262USD91
2025-01-01 to 2025-06-30-91,961USD181
2024-04-01 to 2024-06-301,558,256USD91
2024-01-01 to 2024-06-301,219,799USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-06-30844,770USD181
2024-01-01 to 2024-06-301,083,056USD182

Inspect the source

Entity
Selectis Health, Inc. / CIK 0000727346
Captured
2026-09-19T15:00:26.408Z
SEC response SHA-256
98084fe11a07b9229eef60550e570fcfec8f48e5c4750b74ebaa187a5d31ada2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000727346.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))